Oncology and Hematology

49-64 of 612

Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Project Oncology®
Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
- Jennifer Caudle, DO, FACOFP
- Maxwell Llyod, MD
Addressing Unmet Needs in Metastatic Uveal Melanoma
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
1.00 credit
- Marlana Orloff, MD
- Gregory Daniels, MD, PhD
- Jesse Keller, MD
1.00 credit
The Metabolic Roots of Early-Onset Colorectal Cancer
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®
The Metabolic Roots of Early-Onset Colorectal Cancer
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Project Oncology®
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Clinician's Roundtable
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
Project Oncology®
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
- Charles Turck, PharmD, BCPS, BCCCP
- Andrea Necchi, MD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
- Alexandria May, PharmD, BCPS
- Nicholas Whipple, MD, MPH
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
- Pavani Chalasani, MD, MPH
- Timothy Yap, MBBS, PhD, FRCP
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
- Seth Wander, MD, PhD
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
- Ryan Quigley
- Megan Kruse, MD
Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
AudioAbstracts
Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
- Marlene Mimi Maeusli, PhD.
Adjuvant Nivolumab in High-Risk Muscle Invasive Urothelial Carcinoma: 5-Year Data
Adjuvant Nivolumab in High-Risk Muscle Invasive Urothelial Carcinoma: 5-Year Data
Project Oncology®
Adjuvant Nivolumab in High-Risk Muscle Invasive Urothelial Carcinoma: 5-Year Data
- Brian P. McDonough, MD, FAAFP
- Matthew Galsky, MD
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
- Ryan Quigley
- Kathrin M. Bernt, MD
- Rushabh Mehta, BS
- Fatemeh Alikarami
MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodes
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
- Chelsea Cole, MD
1.00 credit 10 episodes